|
|
Volumn 106, Issue 18, 2002, Pages
|
|
Safety of C1-inhibitor for clinical use.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBIN III;
ANTITHROMBIN III PROTEASE COMPLEX;
ANTITHROMBIN III-PROTEASE COMPLEX;
COMPLEMENT COMPONENT C1S INHIBITOR;
HEPARIN;
PEPTIDE HYDROLASE;
ANIMAL;
COMPLEMENT ACTIVATION;
DISEASE MODEL;
DOG;
DOSE RESPONSE;
DRUG EFFECT;
HEART;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
NOTE;
PILOT STUDY;
RISK;
SWINE;
TREATMENT OUTCOME;
ANIMALS;
ANTITHROMBIN III;
COMPLEMENT ACTIVATION;
COMPLEMENT C1 INACTIVATOR PROTEINS;
COMPLEMENT C1 INHIBITOR PROTEIN;
DISEASE MODELS, ANIMAL;
DOGS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HEART;
HEPARIN;
HUMANS;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
PEPTIDE HYDROLASES;
PILOT PROJECTS;
RISK;
SWINE;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0037195222
PISSN: None
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/01.cir.0000035928.78148.cb Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|
